We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Claims in Truvada Print Ad Lead to Gilead Warning
Claims in Truvada Print Ad Lead to Gilead Warning
April 9, 2010
The FDA has sent Gilead Sciences an untitled letter about a direct-to-consumer print advertisement for its HIV treatment Truvada, saying the ad overstates the efficacy of the drug, makes unsubstantiated claims and minimizes its risks.